Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

NCT00387400 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: everolimus
DRUG: temozolomide
GENETIC: microarray analysis
OTHER: immunohistochemistry staining method

Sponsor

NCIC Clinical Trials Group